Latest Sustainability In It News

Novatti Group has achieved positive operating cashflow and EBITDA for the September quarter, driven by strategic revenue reforms and new commercial contracts with major clients.

Invion Limited has secured a pivotal FDA Orphan Drug Designation for its lead cancer drug INV043, bolstered its balance sheet with nearly $1.8 million in new funding, and progressed clinical trials targeting skin and anogenital cancers.

Prairie Lithium has fast-tracked its flagship Saskatchewan lithium project by initiating fabrication of a commercial-scale extraction unit and securing vital rail access, supported by a US$5 million non-dilutive capital raise and a promising offtake agreement.

Green360 Technologies has independently verified its Eco-Clay product as a high-performance, low-carbon cement substitute made from kaolin waste, poised to disrupt Australia’s $3.5 billion cement market.

Acusensus Limited has secured a significant expansion of its contract with Queensland’s Department of Transport and Main Roads, doubling its trailer-based speed enforcement units with a $16.6 million deal set to roll out from late 2025.

Mach7 Technologies reports a modest rise in recurring revenue alongside a comprehensive commercial transformation, positioning itself for growth in AI-driven medical imaging.

Kuniko Limited has initiated a detailed 328 line-kilometre airborne geophysical survey at its Commonwealth Gold–Silver Project in NSW, aiming to refine drill targets with advanced imaging technology. This marks a key step in advancing exploration within the prolific Lachlan Fold Belt.

Jindalee Lithium reported a challenging quarter with over A$2 million in cash outflows but bolstered its funding position with a recent $8 million share placement, extending its operational runway.

Jindalee Lithium is progressing its McDermitt Lithium Project with a proposed US SPAC listing, government backing, and an $8 million capital raise, positioning it as a key player in the US critical minerals landscape.

Visionflex Group reported a $999,000 cash outflow for Q1 2025 but bolstered its liquidity with $1.9 million in financing, including plans to convert $3 million of convertible notes into equity pending shareholder approval.

Aspermont Limited reports its 37th consecutive quarter of subscription growth, launching its Mining-IQ AI platform and securing a landmark $550k contract with Rio Tinto.

Percheron Therapeutics reports encouraging phase I clinical results for HMBD-002, confirming safety and early efficacy signals, while gearing up for a multi-arm phase II trial in 2026.